March 9, 2016 / 7:18 AM / a year ago

BRIEF-Tissue Regenix granted 510k market clearance from FDA for SurgiPure XD

March 9 (Reuters) - Tissue Regenix Group Plc

* Granted 510k market clearance from food and drug administration for surgipure xd

* Clearance clears surgipure xd for a commercial launch within us in 2016 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below